Article

Remibrutinib inhibits human mast cell and basophil activation induced by serum from Chronic Urticaria patients independently of FcεR1 expression

2022-07-19

Abstract excerpt

<h4>Background: </h4> We aim to investigate the effects of the Bruton’s tyrosine kinase (BTK) inhibitor remibrutinib on human in vitro cell activation induced by serum obtained from chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU) patients. <h4>Methods:</h4> 22 patients with CSU (mean age 52 years, 27% women) and 22 with CIndU (46 years, 27% women) were included. A sex-equivalent control...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 56d8ba40-452d-5fa8-8fb2-571ec8420857
DOI: 10.22541/au.165820326.61728446/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Remibrutinib inhibits human mast cell and basophil activation induced by serum from Chronic Urticaria patients independently of FcεR1 expressionDOI 10.22541/au.165820326.61728446/v1Read

Comparable actions of omalizumab on mast cells and basophils.Semantic proximity Read

Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria.Semantic proximity Read

Treatment of Chronic Spontaneous Urticaria With Benralizumab: Report of Primary Endpoint Completer Analysis, Secondary and Exploratory EndpointsSemantic proximity Read

Unveiling chronic spontaneous urticaria pathophysiology through systems biologySemantic proximity Read

Omalizumab treated urticaria patients display T cell and thrombocyte-associated gene regulationSemantic proximity Read

The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors.Semantic proximity Read

Bruton’s tyrosine kinase (BTK) is indispensable in Neutrophils to initiate and maintain Skin Inflammation in a Model of Pemphigoid DiseasesSemantic proximity Read

Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine KinaseSemantic proximity Read

The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.Semantic proximity Read

Advances in Understanding and Managing Chronic UrticariaSemantic proximity Read

The JAK1/3 inhibitor tofacitinib regulates Th cell profiles and humoral immune responses in myasthenia gravisSemantic proximity Read

Anti-FcεRI autoantibody and other mast cell activation-related molecules in Crohn’s diseaseSemantic proximity Read